Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy

被引:2
|
作者
Esen, Ebru [1 ]
Sizmaz, Selcuk [1 ]
Demircan, Nihal [1 ]
机构
[1] Cukurova Univ, Sch Med, Dept Ophthalmol, Adana, Turkey
关键词
Central serous chorioretinopathy; Photodynamic therapy; Optical coherence tomography; Outer nuclear layer; Choroidal thickness; OPTICAL COHERENCE TOMOGRAPHY; SUBFOVEAL CHOROIDAL THICKNESS; PHOTORECEPTOR OUTER SEGMENT; MORPHOLOGIC CHANGES; NUCLEAR LAYER; VERTEPORFIN; EYES; OUTCOMES;
D O I
10.1016/j.pdpdt.2021.102347
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To evaluate the retinal and choroidal microstructural changes at fovea after half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC), using optical coherence tomography (OCT). Methods: The study included 35 eyes with unilateral chronic CSC treated with half-dose PDT. The foveal outer nuclear layer (ONL) and subfoveal choroidal thickness (SFCT) in the affected eyes were compared with baseline measurements at month 1, 3, and 6 after half-dose PDT, and those of the healthy contralateral eyes. Results: The mean baseline ONL thickness of the affected eyes was thinner compared to unaffected fellow eyes (66.9 +/- 16.5 mu m vs 111.5 +/- 11.6 mu m, p<0.001), and increased significantly to 68.6 +/- 17.0 mu m at month 3 and 68.9 +/- 17.3 mu m at month 6 after treatment (p = 0.025 and p = 0.014 respectively). The mean baseline SFCT of the affected eyes was thicker compared to unaffected fellow eyes (399.9 +/- 87.0 mu m vs 338.2 +/- 75.4 mu m, p<0.001), and decreased significantly after treatment at month 1, 3, and 6 (374.0 +/- 84.8 mu m, 369.7 +/- 81.8 mu m, 367.3 +/- 80.8 mu m respectively, p<0.001 for all). The responder group (n = 26), in which subretinal fluid was completely resorbed, showed a significant increase in ONL thickness and decrease in SFCT after treatment, whereas in the non-responder group (n = 9) ONL thickness and SFCT did not differ after treatment. Conclusions: In CSC patients, significant changes are observed in foveal ONL thickness and SFCT after half-dose PDT. ONL thickness and SFCT are suggested to be considered in the OCT examinations of CSC patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
    van Rijssen, Thomas J.
    van Dijk, Elon H. C.
    Scholz, Paula
    MacLaren, Robert E.
    Fauser, Sascha
    Downes, Susan M.
    Hoyng, Carel B.
    Boon, Camiel J. F.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (04) : 905 - 910
  • [42] Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Mao, Jian-Bo
    Zhang, Cai-Yun
    Liu, Chen-Yi
    Zhang, Yun
    Lin, Jing-Jing
    Xu, Zhao-Kai
    Chen, Yi-Qi
    Fan, Yuan-Yuan
    Zhao, Shi-Xin
    Shen, Li-Jun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2021, 14 (05) : 719 - 724
  • [43] Half-dose photodynamic therapy for chronic central serous chorioretinopathy: Efficacy and safety outcomes in real world
    Neves, Filipe
    Costa, Joao
    Fonseca, Sofia
    Silva, Luis
    Agrelos, Luis
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2016, 14 : 173 - 177
  • [44] Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Jian-Bo Mao
    Cai-Yun Zhang
    Chen-Yi Liu
    Yun Zhang
    Jing-Jing Lin
    Zhao-Kai Xu
    Yi-Qi Chen
    Yuan-Yuan Fan
    Shi-Xin Zhao
    Li-Jun Shen
    International Journal of Ophthalmology, 2021, 14 (05) : 719 - 724
  • [45] FLUORESCEIN ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY WITH HALF-DOSE VERTEPORFIN FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
    Koytak, Arif
    Erol, Kazim
    Coskun, Erol
    Asik, Nihal
    Ozturk, Hakan
    Ozerturk, Yusuf
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (10): : 1698 - 1703
  • [46] Foveal and Extrafoveal Effects of Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Cohort Study
    Pinto, Christophe
    Sousa, Keissy
    Oliveira, Eliana
    Mendonca, Luis
    Gentil, Rita
    Queiros, Lara
    Falcao, Manuel
    SEMINARS IN OPHTHALMOLOGY, 2022, 37 (02) : 153 - 157
  • [47] Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy
    Torres-Costa, Sonia
    Penas, Susana
    Cerqueira, Ana Rita
    Brandao, Elisete
    Carneiro, Angela
    Rocha-Sousa, Amandio
    Falcao-Reis, Fernando
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 34
  • [48] Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
    Thomas J. van Rijssen
    Elon H. C. van Dijk
    Paula Scholz
    Robert E. MacLaren
    Sascha Fauser
    Susan M. Downes
    Carel B. Hoyng
    Camiel J. F. Boon
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 905 - 910
  • [49] Angiographic and Tomographic Prognostic Factors of Chronic Central Serous Chorioretinopathy Treated with Half-Dose Photodynamic Therapy
    Chung, Chung Yee
    Chan, Yee Yan
    Li, Kenneth K. W.
    OPHTHALMOLOGICA, 2018, 240 (01) : 37 - 44
  • [50] A combination therapy of half-dose verteporfin photodynamic therapy and intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
    Toklu, Yasin
    Cakmak, Hasan Basri
    Yorgun, Mucella Arikan
    Ergun, Sule Berk
    Simsek, Saban
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (04) : 681 - 688